Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Research Funding » Tetracore Wins NIH Funds for Chikungunya/Dengue MDx on Its POC Thermocycler

Tetracore Wins NIH Funds for Chikungunya/Dengue MDx on Its POC Thermocycler

Jan 30, 2015
|
Madeleine Johnson
Premium

NEW YORK (GenomeWeb) – Rockville, Md.-based diagnostics firm Tetracore has been awarded a one-year grant from the National Institute of Allergy and Infectious Diseases to develop a point-of-care, real-time reverse-transcriptase PCR assay that detects and distinguishes dengue and chikungunya viruses.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

Another Paper Gone

Retraction Watch writes that a cancer researcher has had an eighth paper retracted.

Computational Biologist James Taylor Dies

Computational biologist James Taylor has died, according to Johns Hopkins University.

Ever Infected

The Centers for Disease Control and Prevention is starting to test people for SARS-CoV-2 antibodies, according to the New York Times.

PLOS Papers on Hepatocellular Carcinoma Immune Cells, Regulatory Prostate Cancer Risk SNPs, More

In PLOS this week: features of tumor-infiltrating immune cells, regulatory effects of SNPs associated with prostate cancer risk, and more.

May
06
Featured Webinar

The Role of Single-Cell Functional Biomarkers in Next-Generation Cancer Therapies

Sponsored by
Isoplexis

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.

What's Popular?

In Infectious Disease

  1. Luminex Receives FDA Emergency Use Authorization for Second SARS-CoV-2 Assay

  2. With Sputum Test for SARS-CoV-2, MicroGen Dx Aims to Challenge Quest, LabCorp

  3. Mass General, CHOP, Northwestern Med Get FDA EUAs for SARS-CoV-2 Tests

  4. Co-Diagnostics Gets FDA Emergency Use Authorization for Coronavirus Test

  5. BGI, Aid Genomics Partner to Build COVID-19 Testing Lab in Gaza

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.